Randomized Clinical Trial “Olfactory Dysfunction After COVID-19: Olfactory Rehabilitation Therapy vs. Treatment with Palmitoylethanolamide and Luteolin” – Preliminary Results
The article “Randomized clinical trial ‘olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin’: preliminary results”, published in the European Review for Medical and Pharmacological Sciences by Prof. Di Stadio et al., examines a clinically relevant issue: the long-term persistence of smell and taste disorders after COVID-19 infection.
The study evaluates a structured three-phase therapy and shows that treated patients recovered olfactory function in approximately two months. Prof. Di Stadio further explores the topic in an interview with Il Fatto Quotidiano (full interview available at the following link).